FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2025
Back to search
Official data from USPTO
INDIMIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/02/2025
Trademark type
Word
Nice classes
1, 5
Filing date
06/21/2022
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
08/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
MESSICK, TABITHA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
INDICAL BIOSCIENCE GmbH
Representatives
Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological reagents for industrial and scientific purposes and laboratory analysisother than in vivo use and other than for medical or veterinary purposes; Chemicalbiochemical and biotechnological substances for industrial and scientific purposes and laboratory analysisother than in vivo use and other than for medical or veterinary purposes; Biochemicals for scientific and research usefor sample preparationmodification and manipulation of cells and for labelingisolationpurificationamplification and analysis of natural and synthetic biopolymers in the nature of nucleotidesbuffer substances such as salts and proteins for industrial usemacromolecules and biologically active substancesnone of the foregoing for medical or veterinary use; biochemicalssmall molecular chemicals for scientific or research use; laboratory chemicalssmall molecular chemicals used for the detection of nucleic acids in cell and tissue analysis for in vitro diagnostic use; chemicals and biochemical preparations used in industryin particularchemical and biochemical substances for molecular biologicalbiochemical and immunological laboratory testing and analysisother than for medical or veterinary purposes; kits comprising biochemical reagents for scientific and research usefor sample preparationmodification and manipulation of samples and cells and for labelingseparationisolationpurificationespecially amplification and analysis of natural and synthetic biopolymersin particularnucleic acids for laboratory useoligonucleotidesproteins for industrial usemacromolecules and biologically active substancesnone of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci
Class 5
Pharmaceutical medical preparations for treating infections; veterinary medical productsvaccines; medical products for medical healthcare purposesreagents for medical use; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposesdiagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposesbiological diagnostic agents for testing diseases in cattlepigsother animals; kits comprised of reagents for medical useof antisense oligonucleotides being pharmaceutical preparations of monoclonal antibodies for use in disease testingof in-vitro diagnostic reagents and diagnostic control reagents all for medical purposessold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomoleculesantisense oligonucleotides being pharmaceutical preparationsprimers in the nature of nucleic acid sequences and probes in the nature of single stranded sequences for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medicalveterinarydental purposes; products for medical and veterinary medical purposesdiagnostic preparations for sample preparationfor modification and manipulation of cells and for labellingfor separationfor isolationfor purificationfor amplification and for analysis of natural and synthetic biopolymersin the nature of nucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substances all being diagnostic medical preparations; chemicalbiochemical and biotechnological productsreagents for medical usefor sample preparationfor modification and manipulation of cellsall for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents; buffers for medical and veterinary purposesextraction buffers; diagnostic disease testing kits comprised of chemical reagents for medical useantisense oligonucleotides being pharmaceutical preparationsnucleotides being pharmaceutical preparationsextraction buffersin-vitro diagnostic preparationsdiagnostic control reagentsall for medical and veterinary usesold as a unit for medical and veterinary use
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/11/2025
FIMP
FINAL DISPOSITION PROCESSED
07/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/14/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBO
PUBLISHED FOR OPPOSITION
09/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/28/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/28/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2024
GNRT
NON-FINAL ACTION E-MAILED
01/09/2024
CNRT
NON-FINAL ACTION WRITTEN
01/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
06/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/09/2023
CNRT
NON-FINAL ACTION WRITTEN
04/08/2023
DOCK
ASSIGNED TO EXAMINER
04/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2022
Continuous trademark protection
Get notified about every new filing that threatens INDIMIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.